Y020-8603 Screening compound: 2-[1-(tetrahydro-2-furanylmethyl)-1,2-dihydro[1,3,5]triazino[1,2-a][1,3]benzimidazol-3(4H)-yl]-1-ethanol

Y020-8603 Screening compound: 2-[1-(tetrahydro-2-furanylmethyl)-1,2-dihydro[1,3,5]triazino[1,2-a][1,3]benzimidazol-3(4H)-yl]-1-ethanol
Y020-8603 Screening compound: 2-[1-(tetrahydro-2-furanylmethyl)-1,2-dihydro[1,3,5]triazino[1,2-a][1,3]benzimidazol-3(4H)-yl]-1-ethanol alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-8603
2-[1-(tetrahydro-2-furanylmethyl)-1,2-dihydro[1,3,5]triazino[1,2-a][1,3]benzimidazol-3(4H)-yl]-1-ethanol

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-8603

Molecular Formula

C16H22N4O2 (C16 H22 N4 O2)

Compound Name

2-[1-(tetrahydro-2-furanylmethyl)-1,2-dihydro[1,3,5]triazino[1,2-a][1,3]benzimidazol-3(4H)-yl]-1-ethanol

IUPAC name

2-{10-[(oxolan-2-yl)methyl]-181012-tetraazatricyclo[7.4.0.0^{27}]trideca-2468-tetraen-12-yl}ethan-1-ol

SMILES

OCCN1CN(CC2OCCC2)c2nc(cccc3)c3n2C1

InChI

InChI=1S/C16H22N4O2/c21-8-7-18-11-19(10-13-4-3-9-22-13)16-17-14-5-1-2-6-15(14)20(16)12-18/h1-2,5-6,13,21H,3-4,7-12H2/t13-/m1/s1

InChI Key

MQHLCSDHPSRHFI-CYBMUJFWSA-N

MDL Number (MFCD)

MFCD09430679

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

302.38

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.073

Distribution Coefficient, logD

0.703

Water Solubility, LogSw

-1.83

Polar Surface Area

43.309

Acid Dissociation Constant (pKa)

14.97

Base Dissociation Constant (pKb)

8.75

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

56.30

Y020-8603 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

DGK Inhibitors Library (10558 compounds)

GPCR Targeted Library (31838 compounds)

Nucleic Acid Ligands (8311 compounds)

Nucleoside Mimetics Library (2197 compounds)

Purine Based Nucleoside Mimetics Library (1131 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Antiviral
  • Infections
  • Cancer
  • Immune system
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with Y020-8603 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-8603?
Check Price and Availability of Y020-8603, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-8603 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-8603
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-8603
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-8603 available by request